Highlights
KLSE: DKSH (5908)       DKSH HOLDINGS MALAYSIA BHD MAIN : Consumer
Last Price Today's Change   Day's Range   Trading Volume
3.28   +0.01 (0.31%)  3.25 - 3.32  47,500
Analyze this stock with MQ Trader system

Financials


Market Cap: 517 Million

Market Cap 517 Million
NOSH 158 Million

Latest Audited Result:  31-Dec-2019

Latest Audited Result: 31-Dec-2019
Announcement Date 27-May-2020
Next Audited Result: 31-Dec-2020
Est. Ann. Date: 27-May-2021
Est. Ann. Due Date: 29-Jun-2021

Latest Quarter:  30-Sep-2020 [#3]

Latest Quarter: 30-Sep-2020 [#3]
Announcement Date 25-Nov-2020
Next Quarter: 31-Dec-2020
Est. Ann. Date: 19-Feb-2021
Est. Ann. Due Date: 01-Mar-2021
QoQ | YoY   74.16%  |    26.97%

Annual (Unaudited) ( EPS: 24.79, P/E: 13.23 )

Revenue | NP to SH 6,455,088  |  39,085
RPS | P/RPS 4,094.36 Cent  |  0.08
EPS | P/E | EY 24.79 Cent  |  13.23  |  7.56%
DPS | DY | Payout % 10.00 Cent  |  3.05%  |  40.34%
NAPS | P/NAPS 3.93  |  0.83
YoY   -12.39%
NP Margin | ROE 0.61%  |  6.30%
F.Y. | Ann. Date 31-Dec-2019  |  19-Feb-2020

T4Q Result ( EPS: 31.01, P/E: 10.58 )

Revenue | NP to SH 6,415,779  |  48,892
RPS | P/RPS 4,069.43 Cent  |  0.08
EPS | P/E | EY 31.01 Cent  |  10.58  |  9.45%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 4.13  |  0.79
QoQ | YoY   6.30%  |    51.21%
NP Margin | ROE 0.76%  |  7.50%
F.Y. | Ann. Date 30-Sep-2020  |  25-Nov-2020

Annualized Result ( EPS: 26.71, P/E: 12.28 )

Revenue | NP to SH 6,409,606  |  42,102
RPS | P/RPS 4,065.51 Cent  |  0.08
EPS | P/E | EY 26.71 Cent  |  12.28  |  8.14%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   17.38%  |    45.05%
NP Margin | ROE 0.66%  |  6.46%
F.Y. | Ann. Date 30-Sep-2020  |  25-Nov-2020


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Dec-2020 25-Nov-2020 30-Sep-2020 3 6,415,779 75,002 48,892 48,892 0 651,821 - % 0.76% 7.50% 157,658 4,069.43 4,069.43 31.01 31.01 0.00 0.00 4.1344 4.13   6.30%   51.21% 30-Sep-2020 2.90 0.07 9.35 0.70 10.69% 0.00% 25-Nov-2020 3.50 0.09 11.29 0.85 8.86% 0.00%
31-Dec-2020 26-Aug-2020 30-Jun-2020 2 6,490,444 74,416 45,994 45,994 0 638,199 - % 0.71% 7.21% 157,658 4,116.79 4,116.79 29.17 29.17 0.00 0.00 4.0480 4.05   -7.65%   49.43% 30-Jun-2020 2.49 0.06 8.54 0.62 11.72% 0.00% 26-Aug-2020 3.24 0.08 11.11 0.80 9.00% 0.00%
31-Dec-2020 28-May-2020 31-Mar-2020 1 6,615,884 78,714 49,805 49,805 15,765 630,348 31.66% 0.75% 7.90% 157,658 4,196.35 4,196.35 31.59 31.59 10.00 10.00 3.9982 4.00   27.43%   50.06% 31-Mar-2020 1.97 0.05 6.24 0.49 16.04% 5.08% 28-May-2020 2.68 0.06 8.48 0.67 11.79% 3.73%
31-Dec-2019 19-Feb-2020 31-Dec-2019 4 6,455,088 60,996 39,085 39,085 15,765 620,289 40.34% 0.61% 6.30% 157,658 4,094.36 4,094.36 24.79 24.79 10.00 10.00 3.9344 3.93   20.88%   -12.39% 31-Dec-2019 2.62 0.06 10.57 0.67 9.46% 3.82% 19-Feb-2020 2.60 0.06 10.49 0.66 9.53% 3.85%
31-Dec-2019 29-Oct-2019 30-Sep-2019 3 6,444,226 50,649 32,333 32,333 15,765 602,979 48.76% 0.50% 5.36% 157,658 4,087.47 4,087.47 20.51 20.51 10.00 10.00 3.8246 3.82   5.05%   -34.88% 30-Sep-2019 2.54 0.06 12.39 0.66 8.07% 3.94% 29-Oct-2019 2.50 0.06 12.19 0.65 8.20% 4.00%
31-Dec-2019 30-Aug-2019 30-Jun-2019 2 6,249,906 45,665 30,780 30,780 15,765 592,242 51.22% 0.49% 5.20% 157,658 3,964.22 3,964.22 19.52 19.52 10.00 10.00 3.7565 3.76   -7.26%   -38.99% 28-Jun-2019 2.74 0.07 14.03 0.73 7.13% 3.65% 30-Aug-2019 2.51 0.06 12.86 0.67 7.78% 3.98%
31-Dec-2019 31-May-2019 31-Mar-2019 1 6,118,841 46,934 33,189 33,189 15,765 596,341 47.50% 0.54% 5.57% 157,658 3,881.08 3,881.08 21.05 21.05 10.00 10.00 3.7825 3.78   -25.61%   -37.09% 29-Mar-2019 2.34 0.06 11.12 0.62 9.00% 4.27% 31-May-2019 2.58 0.07 12.26 0.68 8.16% 3.88%
31-Dec-2018 25-Feb-2019 31-Dec-2018 4 6,011,839 60,583 44,615 44,615 15,765 597,003 35.34% 0.74% 7.47% 157,658 3,813.21 3,813.21 28.30 28.30 10.00 10.00 3.7867 3.79   -10.15%   -14.19% 31-Dec-2018 2.30 0.06 8.13 0.61 12.30% 4.35% 25-Feb-2019 2.72 0.07 9.61 0.72 10.40% 3.68%
31-Dec-2018 08-Nov-2018 30-Sep-2018 3 5,791,131 67,296 49,655 49,655 15,765 586,440 31.75% 0.86% 8.47% 157,658 3,673.22 3,673.22 31.50 31.50 10.00 10.00 3.7197 3.72   -1.58%   -0.20% 28-Sep-2018 3.35 0.09 10.64 0.90 9.40% 2.99% 08-Nov-2018 3.05 0.08 9.68 0.82 10.33% 3.28%
31-Dec-2018 08-Aug-2018 30-Jun-2018 2 5,645,126 68,310 50,452 50,452 15,765 577,233 31.25% 0.89% 8.74% 157,658 3,580.61 3,580.61 32.00 32.00 10.00 10.00 3.6613 3.66   -4.37%   11.66% 29-Jun-2018 3.38 0.09 10.56 0.92 9.47% 2.96% 08-Aug-2018 3.90 0.11 12.19 1.07 8.21% 2.56%
31-Dec-2018 22-May-2018 31-Mar-2018 1 5,596,359 71,692 52,756 52,756 14,977 578,936 28.39% 0.94% 9.11% 157,658 3,549.68 3,549.68 33.46 33.46 9.50 9.50 3.6721 3.67   1.47%   7.13% 30-Mar-2018 3.85 0.11 11.51 1.05 8.69% 2.47% 22-May-2018 4.30 0.12 12.85 1.17 7.78% 2.21%
31-Dec-2017 26-Feb-2018 31-Dec-2017 4 5,510,354 70,721 51,994 51,994 14,977 568,073 28.81% 0.94% 9.15% 157,658 3,495.13 3,495.13 32.98 32.98 9.50 9.50 3.6032 3.60   4.50%   3.03% 29-Dec-2017 3.98 0.11 12.07 1.10 8.29% 2.39% 26-Feb-2018 3.90 0.11 11.83 1.08 8.46% 2.44%
31-Dec-2017 31-Oct-2017 30-Sep-2017 3 5,459,772 67,930 49,757 49,757 14,977 552,496 30.10% 0.91% 9.01% 157,658 3,463.05 3,463.05 31.56 31.56 9.50 9.50 3.5044 3.50   10.12%   5.46% 29-Sep-2017 4.70 0.14 14.89 1.34 6.71% 2.02% 31-Oct-2017 4.68 0.14 14.83 1.34 6.74% 2.03%
31-Dec-2017 09-Aug-2017 30-Jun-2017 2 5,346,725 61,829 45,183 45,183 14,977 469,505 33.15% 0.85% 9.62% 157,658 3,391.34 3,391.34 28.66 28.66 9.50 9.50 2.9780 2.98   -8.24%   -2.37% 30-Jun-2017 4.90 0.14 17.10 1.65 5.85% 1.94% 09-Aug-2017 5.00 0.15 17.45 1.68 5.73% 1.90%
31-Dec-2017 24-May-2017 31-Mar-2017 1 5,307,918 66,727 49,243 49,243 14,977 468,323 30.42% 0.93% 10.51% 157,658 3,366.73 3,366.73 31.23 31.23 9.50 9.50 2.9705 2.97   -2.43%   37.24% 31-Mar-2017 4.69 0.14 15.02 1.58 6.66% 2.03% 24-May-2017 5.21 0.15 16.68 1.75 6.00% 1.82%
31-Dec-2016 21-Feb-2017 31-Dec-2016 4 5,271,047 68,897 50,467 50,467 14,977 531,086 29.68% 0.96% 9.50% 157,658 3,343.34 3,343.34 32.01 32.01 9.50 9.50 3.3686 3.37   6.96%   37.00% 30-Dec-2016 4.47 0.13 13.96 1.33 7.16% 2.13% 21-Feb-2017 5.31 0.16 16.59 1.58 6.03% 1.79%
31-Dec-2016 22-Nov-2016 30-Sep-2016 3 5,300,530 64,536 47,182 47,182 14,977 517,701 31.74% 0.89% 9.11% 157,658 3,362.04 3,362.04 29.93 29.93 9.50 9.50 3.2837 3.28   1.95%   7.15% 30-Sep-2016 5.55 0.17 18.55 1.69 5.39% 1.71% 22-Nov-2016 6.15 0.18 20.55 1.87 4.87% 1.54%
31-Dec-2016 23-Aug-2016 30-Jun-2016 2 5,468,735 63,458 46,281 46,281 14,977 512,278 32.36% 0.85% 9.03% 157,658 3,468.73 3,468.73 29.36 29.36 9.50 9.50 3.2493 3.25   28.98%   -14.61% 30-Jun-2016 3.68 0.11 12.54 1.13 7.98% 2.58% 23-Aug-2016 4.60 0.13 15.67 1.42 6.38% 2.07%
31-Dec-2016 24-May-2016 31-Mar-2016 1 5,485,851 49,877 35,881 35,881 0 506,823 - % 0.65% 7.08% 157,658 3,479.59 3,479.59 22.76 22.76 0.00 0.00 3.2147 3.21   -2.59%   -38.81% 31-Mar-2016 4.00 0.11 17.58 1.24 5.69% 0.00% 24-May-2016 3.80 0.11 16.70 1.18 5.99% 0.00%
31-Dec-2015 23-Feb-2016 31-Dec-2015 4 5,572,186 51,009 36,836 36,836 0 495,582 - % 0.66% 7.43% 157,658 3,534.35 3,534.35 23.36 23.36 0.00 0.00 3.1434 3.14   -16.34%   -38.52% 31-Dec-2015 4.00 0.11 17.12 1.27 5.84% 0.00% 23-Feb-2016 4.00 0.11 17.12 1.27 5.84% 0.00%
31-Dec-2015 24-Nov-2015 30-Sep-2015 3 5,596,576 60,418 44,032 44,032 0 485,508 - % 0.79% 9.07% 157,658 3,549.82 3,549.82 27.93 27.93 0.00 0.00 3.0795 3.08   -18.76%   -74.20% 30-Sep-2015 4.10 0.12 14.68 1.33 6.81% 0.00% 24-Nov-2015 4.54 0.13 16.26 1.47 6.15% 0.00%
31-Dec-2015 25-Aug-2015 30-Jun-2015 2 5,482,592 73,326 54,197 54,197 0 480,935 - % 0.99% 11.27% 157,658 3,477.52 3,477.52 34.38 34.38 0.00 0.00 3.0505 3.05   -7.57%   -68.72% 30-Jun-2015 5.00 0.14 14.54 1.64 6.88% 0.00% 25-Aug-2015 4.00 0.12 11.64 1.31 8.59% 0.00%
31-Dec-2015 11-May-2015 31-Mar-2015 1 5,471,600 79,292 58,637 58,637 35,473 485,870 60.50% 1.07% 12.07% 157,658 3,470.55 3,470.55 37.19 37.19 22.50 22.50 3.0818 3.08   -2.13%   -66.80% 31-Mar-2015 5.32 0.15 14.30 1.73 6.99% 4.23% 11-May-2015 5.31 0.15 14.28 1.72 7.00% 4.24%
31-Dec-2014 26-Feb-2015 31-Dec-2014 4 5,339,481 80,415 59,911 59,911 35,473 473,636 59.21% 1.12% 12.65% 157,658 3,386.75 3,386.75 38.00 38.00 22.50 22.50 3.0042 3.00   -64.89%   -65.73% 31-Dec-2014 5.38 0.16 14.16 1.79 7.06% 4.18% 26-Feb-2015 5.90 0.17 15.53 1.96 6.44% 3.81%
31-Dec-2014 13-Nov-2014 30-Sep-2014 3 5,236,251 188,610 170,950 170,646 0 456,341 - % 3.26% 37.39% 157,658 3,321.27 3,321.27 108.24 108.24 0.00 0.00 2.8945 2.89   -1.50%   93.64% 30-Sep-2014 6.47 0.19 5.98 2.24 16.73% 0.00% 13-Nov-2014 6.54 0.20 6.04 2.26 16.55% 0.00%
31-Dec-2014 26-Aug-2014 30-Jun-2014 2 5,212,962 190,759 174,581 173,244 0 441,663 - % 3.35% 39.23% 157,658 3,306.50 3,306.50 109.89 109.89 0.00 0.00 2.8014 2.80   -1.91%   109.57% 30-Jun-2014 8.28 0.25 7.54 2.96 13.27% 0.00% 26-Aug-2014 6.56 0.20 5.97 2.34 16.75% 0.00%
31-Dec-2014 20-May-2014 31-Mar-2014 1 5,129,096 193,722 179,074 176,622 18,134 462,679 10.27% 3.49% 38.17% 157,658 3,253.30 3,253.30 112.03 112.03 11.50 11.50 2.9347 2.93   1.03%   124.96% 31-Mar-2014 9.00 0.28 8.03 3.07 12.45% 1.28% 20-May-2014 7.81 0.24 6.97 2.66 14.34% 1.47%
31-Dec-2013 26-Feb-2014 31-Dec-2013 4 5,085,623 190,445 178,342 174,828 18,134 449,192 10.37% 3.51% 38.92% 157,661 3,225.67 3,225.73 110.89 110.89 11.50 11.50 2.8491 2.85   98.38%   124.82% 31-Dec-2013 6.45 0.20 5.82 2.26 17.19% 1.78% 26-Feb-2014 7.00 0.22 6.31 2.46 15.84% 1.64%
31-Dec-2013 21-Nov-2013 30-Sep-2013 3 5,012,195 105,727 92,496 88,126 18,134 319,416 20.58% 1.85% 27.59% 157,627 3,179.77 3,179.16 55.91 55.90 11.50 11.50 2.0264 2.03   6.61%   84.97% 30-Sep-2013 5.90 0.19 10.55 2.91 9.48% 1.95% 21-Nov-2013 6.42 0.20 11.48 3.17 8.71% 1.79%
31-Dec-2013 28-Aug-2013 30-Jun-2013 2 4,920,762 101,426 87,084 82,665 29,176 302,248 35.30% 1.77% 27.35% 157,692 3,120.48 3,121.16 52.42 52.43 18.50 18.51 1.9167 1.92   5.29%   78.55% 28-Jun-2013 5.03 0.16 9.60 2.62 10.42% 3.68% 28-Aug-2013 5.07 0.16 9.67 2.65 10.34% 3.65%
31-Dec-2013 22-May-2013 31-Mar-2013 1 4,859,943 100,315 82,860 78,512 22,075 302,657 28.12% 1.70% 25.94% 157,749 3,080.80 3,082.58 49.77 49.80 14.00 14.00 1.9186 1.92   0.96%   76.68% 29-Mar-2013 3.25 0.11 6.53 1.69 15.31% 4.31% 22-May-2013 5.44 0.18 10.93 2.84 9.15% 2.57%
31-Dec-2012 28-Feb-2013 31-Dec-2012 4 4,740,105 102,119 81,810 77,762 22,075 290,860 28.39% 1.73% 26.74% 157,681 3,006.12 3,006.57 49.32 49.32 14.00 14.00 1.8446 1.84   63.22%   76.34% 31-Dec-2012 2.25 0.07 4.56 1.22 21.92% 6.22% 28-Feb-2013 2.87 0.10 5.82 1.56 17.18% 4.88%
31-Dec-2012 23-Nov-2012 30-Sep-2012 3 4,579,255 72,678 51,534 47,643 22,075 254,629 46.34% 1.13% 18.71% 157,743 2,902.97 2,904.55 30.20 30.22 14.00 14.00 1.6142 1.62   2.91%   9.90% 28-Sep-2012 2.14 0.07 7.09 1.33 14.11% 6.54% 23-Nov-2012 2.17 0.07 7.18 1.34 13.92% 6.45%
31-Dec-2012 24-Aug-2012 30-Jun-2012 2 4,474,354 71,599 50,565 46,297 18,128 242,634 39.16% 1.13% 19.08% 157,626 2,838.58 2,838.01 29.37 29.37 11.50 11.50 1.5393 1.54   4.18%   7.11% 29-Jun-2012 2.12 0.07 7.22 1.38 13.85% 5.42% 24-Aug-2012 2.05 0.07 6.98 1.33 14.33% 5.61%
31-Dec-2012 25-May-2012 31-Mar-2012 1 4,313,139 68,211 48,940 44,438 14,187 239,985 31.93% 1.13% 18.52% 157,625 2,736.31 2,735.76 28.19 28.19 9.00 9.00 1.5225 1.52   0.77%   23.27% 30-Mar-2012 1.95 0.07 6.92 1.28 14.46% 4.62% 25-May-2012 1.91 0.07 6.77 1.25 14.76% 4.71%
31-Dec-2011 24-Feb-2012 31-Dec-2011 4 4,260,749 67,687 48,872 44,098 14,187 229,078 32.17% 1.15% 19.25% 157,605 2,703.43 2,702.53 27.98 27.97 9.00 9.00 1.4535 1.45   1.72%   58.05% 30-Dec-2011 1.56 0.06 5.58 1.07 17.94% 5.77% 24-Feb-2012 1.86 0.07 6.65 1.28 15.04% 4.84%
31-Dec-2011 29-Nov-2011 30-Sep-2011 3 4,205,857 67,854 48,552 43,352 14,187 210,919 32.73% 1.15% 20.55% 157,649 2,667.85 2,667.71 27.50 27.50 9.00 9.00 1.3379 1.34   0.30%   72.66% 30-Sep-2011 1.46 0.05 5.31 1.09 18.83% 6.16% 29-Nov-2011 2.06 0.08 7.49 1.54 13.35% 4.37%
31-Dec-2011 26-Aug-2011 30-Jun-2011 2 4,099,941 66,260 47,822 43,223 12,535 200,358 29.00% 1.17% 21.57% 157,625 2,601.06 2,600.53 27.42 27.42 7.95 7.95 1.2711 1.27   19.90%   80.35% 30-Jun-2011 1.47 0.06 5.36 1.16 18.65% 5.41% 26-Aug-2011 1.46 0.06 5.32 1.15 18.78% 5.45%
31-Dec-2011 19-May-2011 31-Mar-2011 1 3,995,980 55,944 40,410 36,049 10,882 195,728 30.19% 1.01% 18.42% 157,769 2,532.80 2,534.59 22.85 22.87 6.90 6.90 1.2406 1.24   29.20%   57.74% 31-Mar-2011 0.95 0.04 4.16 0.77 24.05% 7.26% 19-May-2011 1.25 0.05 5.47 1.01 18.28% 5.52%
31-Dec-2010 25-Feb-2011 31-Dec-2010 4 3,867,610 45,556 31,973 27,902 10,882 184,998 39.00% 0.83% 15.08% 157,740 2,451.87 2,453.16 17.69 17.70 6.90 6.90 1.1728 1.17   11.13%   31.08% 30-Dec-2010 1.05 0.04 5.94 0.90 16.85% 6.57% 25-Feb-2011 0.81 0.03 4.58 0.69 21.84% 8.52%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Trade this stock for as low as 0.05% brokerage. Find out more.
  6 people like this.
 
lbkeat dksh now not just a trading but combination of both manufacturing com(with reputable brand )and trading taiko in malaysia and singapore. so, it depends on how much pe u willing to give. If its transportation segment can back to precovid level , im looking eps more than 10 sen per q in fy21.
26/11/2020 11:20 AM
mrmeow AHEALTH has the cold storage facility and has expanded by acquiring more cold facility and prepared for the covid19 vaccines. Don't foget this real making money one, supplying Msia and Singapore, stable & growing business even before covid, always on an uptrend
26/11/2020 11:31 PM
super_newbie Gov't inks deal with Pfizer to vaccinate 6.4 million Malaysians

https://www.nst.com.my/news/nation/2020/11/644852/govt-inks-deal-pfizer-vaccinate-64-million-malaysians

While the world is holding its breath awaiting the release of the first COVID-19 vaccine, DKSH is already looking at how we can ensure that a vaccine can reach people in all corners of Asia. As one of Asia’s biggest vaccine distributors, it’s our mission to help Asian patients.

https://www.dksh.com/global-en/insights/opportunities-and-challenges-to-bringing-a-covid-19-vaccine-to-asian-citizens
27/11/2020 5:00 PM
Humble_Investor https://www.theedgemarkets.com/article/malaysia-has-signed-initial-agreement-pfizer-procure-128-million-doses-covid19-vaccine
28/11/2020 1:46 AM
NPRA1985 UK set to approve Pfizer-BioNTech Covid vaccine within days

https://www.ft.com/content/ebd9ca50-c2d7-4b0e-afd5-e90e93c0c495
29/11/2020 3:15 AM
mrmeow APEX HEALTH (AHEALTH) has been approached by several manufacturers to be the authorised distributor for their upcoming Covid-19 vaccines (work-in-progress). There are many considerations in evaluating these proposals (ie. whether the products will be approved, pricings, efficiencies, requirements, etc) and hence, Apex has not committed to any manufacturer. Instead, the group will likely start off as a wholesaler, where Apex will distribute the Covid-19 vaccines from various manufacturers''

AffinHWang
29/11/2020 12:16 PM
NPRA1985 PM: No call to reject 2021 Budget just to bring about polls

"There is no need to do that (reject the 2021 Budget). If you ask me, I could have yesterday advised the Yang di-Pertuan Agong Al-Sultan Abdullah Ri'ayatuddin Al-Mustafa Billah Shah, to dissolve Parliament so that a general election can be held.

"But we all know that the problem is Covid-19. InsyaAllah, if He allows it, when the pandemic is over, we can hold a general election.

Muhyiddin added that the 2021 Budget, worth RM322.5 billion which was passed at the policy level in Parliament on Thursday, is aimed at easing the burden of the people and restoring the country's economy.

"I hope the 2021 Budget will be approved at the Dewan Rakyat and subsequently at the Dewan Negara. This is to ensure that the people will receive the assistance that they need during this tough time."

https://www.nst.com.my/news/politics/2020/11/645117/pm-no-call-reject-2021-budget-just-bring-about-polls
29/11/2020 9:23 PM
NPRA1985 No significant change to reject budget at committee level: Dr M

FORMER Prime Minister (PM) Tun Dr Mahathir Mohamad said no significant change can be achieved if the proposed Budget 2021 is rejected at the committee level debate session.

“Rejecting the budget at the committee level, as it is said to be done, will not bring any significant impact on the government nor the proposed budget.

“It is just an attempt to divert the criticisms of the people who are disappointed with the attitude of the Opposition,” Dr Mahathir said in a statement today.

https://themalaysianreserve.com/2020/11/27/no-significant-change-to-reject-budget-at-committee-level-dr-m/
29/11/2020 9:35 PM
super_newbie Telstar Lifesciences-General Lab Equipment-Ultra Low Temperature freezers (-86°C & -45°C)

https://www.dksh.com/global-en/products/ins/telstar-ultra-low-temperature-freezers
30/11/2020 9:50 AM
tuapuikia Come on !!!
30/11/2020 11:05 AM
NPRA1985 U.K. Approves Pfizer Coronavirus Vaccine, a First in the West
The emergency approval, ahead of the United States and the European Union, clears the way for Britain to begin mass inoculations. “Help is on its way,” one official said.

https://www.nytimes.com/2020/12/02/world/europe/pfizer-coronavirus-vaccine-approved-uk.html
02/12/2020 6:29 PM
investorking2020 Congratulations to Pfizer! But Pfizer is not distributed by DKSH in Malaysia.
02/12/2020 7:31 PM
Sean Eng Kwong Howe Lmost all pfizr product are by dksh
02/12/2020 7:34 PM
stan888 With pfizer approved in UK...it will be widely distribute in other countries...whether Dksh will be the main distributor is still a question...BUT...they are the biggest pharmaceutical/medical distributor in Malaysia..so ..wait and see
03/12/2020 8:21 AM
NPRA1985 Forwarders see their cargo bumped as vaccine shipments take off

https://theloadstar.com/forwarders-see-their-cargo-bumped-as-vaccine-shipments-take-off/
03/12/2020 11:30 AM
investorking2020 In the interest of facts versus fiction, suggest to check MIMS who is the main distributor for Pfizer Rx products in Malaysia. It is not DKSH. At the same time, DKSH is also by far NOT the biggest pharma distributor in Malaysia.
03/12/2020 12:31 PM
huat8787 https://www.dksh.com/hea/dkshpro/home
03/12/2020 1:33 PM
investorking2020 There is a difference between a marketing pamphlet declaring something the "leading growth partner" (God knows what that is) and being the biggest pharma distributor. But believe what you want if it makes you feel better.
03/12/2020 2:40 PM
super_newbie US dollar weakening favor distributor or importer as cost of good sold is cheaper?
03/12/2020 3:28 PM
NPRA1985 DUBAI: Bahrain said on Friday it has granted emergency use authorization for the Pfizer/BioNTech COVID-19 vaccine, becoming the second country after Britain to approve it.

The kingdom had also approved Sinopharm’s COVID-19 vaccine in November for use by frontline workers.

https://www.arabnews.com/node/1772516/middle-east
05/12/2020 1:36 AM
NPRA1985 South Korea reaches deal to buy AstraZeneca's Covid-19 vaccine candidate

https://www.straitstimes.com/asia/east-asia/south-korea-reaches-deal-to-buy-astrazenecas-covid-19-vaccine-candidate
05/12/2020 1:48 AM
NPRA1985 500 million vaccine doses in Q1 2021 closer to reality, says WHO

https://www.freemalaysiatoday.com/category/world/2020/12/05/500-million-vaccine-doses-in-q1-2021-closer-to-reality-says-who/
05/12/2020 2:34 PM
tuapuikia please wake up
08/12/2020 1:35 PM
Chong1116 Maybe this time coming true....
08/12/2020 6:09 PM
NPRA1985 UAE says Sinopharm vaccine has 86% efficacy against COVID-19

DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.

The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.

The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.

“The analysis shows no serious safety concerns,” it said.

It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.

https://www.reuters.com/article/health-coronavirus-emirates/update-1-uae-says-sinopharm-vaccine-has-86-efficacy-against-covid-19-idUSL1N2IP09V
09/12/2020 3:27 PM
NPRA1985 United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19

TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.

The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.

The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.

The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”

The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.

https://www.forbes.com/sites/roberthart/2020/12/09/united-arab-emirates-claims-chinas-sinopharm-vaccine-is-100-effective-at-preventing-moderate-and-severe-covid-19/?sh=2a60fb42595c
09/12/2020 10:24 PM
NPRA1985 Kanger International Bhd has roped in Zuellig Pharma Sdn Bhd and K-Star Sport Ltd to collaborate on the distribution of Covid-19 vaccines in Malaysia.

The vaccine and other products are developed by state-owned China National Pharmaceutical Group Corp (Sinopharm).

In a filing with Bursa Malaysia today, Kanger said it has entered into a memorandum of understanding (MoU) with Zuellig Pharma, the largest vaccine distributor in Malaysia and in Asia, to facilitate the import, warehousing and distribution of Covid-19 vaccines in Malaysia.

Separately, Kanger announced that it has also entered into an MoU with K-Star to appoint the latter as the sales agent of Covid-19 vaccines for private clinics in Malaysia.

Kanger said both MoUs will add value to the group as it is now focused on expanding its business into the healthcare industry, which includes the distribution of Covid-19 vaccines, and is looking for a well-established logistics and distribution provider.

https://www.theedgemarkets.com/article/kanger-ropes-more-collaborators-help-distribute-covid19-vaccines
09/12/2020 11:14 PM
edwinnnnn https://youtu.be/8sT0dmoYqgE
10/12/2020 1:13 PM
MK76 Ada positif dan negatif komen. Seimbang. Beli 1000 unit join korang
10/12/2020 4:21 PM
NPRA1985 Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing.

“The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people.

“Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed.

SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there.

https://asiatimes.com/2020/12/uae-gives-chinese-vaccines-a-shot-in-the-arm/
10/12/2020 11:50 PM
MK76 Vaksin sudah approve. ayuh dksh!
12/12/2020 3:13 PM
NPRA1985 Bursa Malaysia is expected to trend higher next week

https://www.malaymail.com/news/money/2020/12/12/bursa-malaysia-is-expected-to-trend-higher-next-week/1931258

----------------

Bursa Malaysia expected to break 1,700 psychological level

Bursa Malaysia is expected to trend higher next week, with the key FTSE Bursa Malaysia KLCI (FBM KLCI) breaking the psychological level of 1,700, and poised to march into the new year with a big bang.

https://themalaysianreserve.com/2020/12/12/bursa-malaysia-expected-to-break-1700-psychological-level/
12/12/2020 6:00 PM
NPRA1985 Bahrain Approves China’s Sinopharm Covid-19 Vaccine

Bahrain approved the registration of the Sinopharm Group Co Ltd. vaccine against the coronavirus, about a week after the United Arab Emirates registered the Chinese-made vaccine.

“Results from Phase III clinical trials showed an 86% efficacy rate, a 99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of Covid-19,” the National Health Regulatory Authority said in a statement Sunday.

Bahrain has participated in phase III clinical trials, in which more than 7,700 volunteers signed up. Bahrain had previously authorized the emergency use of the vaccine, which was provided to frontline workers in contact with coronavirus patients.

The UAE registered the Sinopharm vaccine after finding it had a 86% efficacy rate, paving the way for a full public use and allowing for a re-opening of the Gulf nation’s economy.

Egypt plans to start the process of inoculation against the coronavirus after receiving the first shipments of Sinopharm vaccine.

https://www.bloomberg.com/news/articles/2020-12-13/bahrain-approves-china-s-sinopharm-covid-19-vaccine

https://abcnews.go.com/Health/wireStory/bahrain-approves-chinese-covid-19-vaccine-74699175
13/12/2020 5:20 PM
MK76 Pfizer sign agreement ngan dksh taiwan.

https://www.dksh.com/tw-en/home/media/news?id=tag:xml.newsbox.ch,2020-12-10:1101.2844.digest
14/12/2020 6:16 AM
tuapuikia https://www.thestar.com.my/news/nation/2020/12/19/govt-to-seal-covid-19-vaccine-purchase-deal-with-astrazeneca-on-monday-dec-21-says-health-minister
19/12/2020 7:34 PM
tuapuikia https://www.theedgemarkets.com/article/publicinvest-upgrades-dksh-raises-target-price-rm380
19/12/2020 7:35 PM
tuapuikia Can checkout dksh, In a note today, the research house said this may well be linked to its long-term relationship with AstraZeneca and Pfizer, one of the many frontrunners in the development of a Covid-19 vaccine, and the possibilities of it being a distribution arm should either one be commercially viable.
19/12/2020 7:35 PM
tuapuikia Monday, gov buy from Astrazeneca. It is time to goreng
19/12/2020 7:36 PM
MK76 Nak kebaboom? Dua minggu je tu.

When asked for comment on the specifics of the storage and distribution of Pfizer’s Covid-19 vaccine, Pfizer Malaysia declined to speak, telling CodeBlue that it would make an announcement in two weeks.

https://codeblue.galencentre.org/2020/12/14/malaysias-biggest-logistical-challenge-in-history-covid-19-vaccination/
21/12/2020 1:44 PM
edwinnnnn https://www.dksh.com/global-en/home/healthcare/covid19-vaccine-distribution?utm_campaign=Oktopost-4_Group_HEC
28/12/2020 12:02 PM
tuapuikia go go go
28/12/2020 4:06 PM
investorking2020 Sorry, that is pointless speculation without any base. But apparently a few misguided can impact the share price with peanuts trading volumes. But as quickly as it raises, as quickly it drops. Good luck!
28/12/2020 9:49 PM
goodboyishere So, which company's shares do you recommend, @investorking2020?
28/12/2020 10:15 PM
Michael_Paul "...due to long-standing relationships, Pfizer is likely to use pharmaceutical distributors Zuellig Pharma or DKSH to distribute its Covid-19 vaccine in Malaysia." Excerpt from https://codeblue.galencentre.org/2020/12/14/malaysias-biggest-logistical-challenge-in-history-covid-19-vaccination/
28/12/2020 11:29 PM
Sandyroxy I am very very positive on DKSH potential looking at the business model of having consumer/distribution/logistic/pharmaceutical supplies businesses. To me it is like having Nestle and Zhuellig business combine. This is a GEM STOCK TO BUY AND HAVE SHORT TERM AND LONG TERM GAIN.
29/12/2020 7:41 AM
MK76 Vaksin dari Pfizer nak sampai bulan Februari. bila dksh nak terbang? Menteri jgnlah main politik je. Siapa yg nak handle vaksin Pfizer nie?
04/01/2021 2:59 PM
gloveharicut I pick DKSH in the contest. Only a few members pick it. Not many see the potential now.

https://klse.i3investor.com/blogs/stock_pick_2021/2021-01-04-story-h1539144072-Stock_Pick_Year_2021_Who_Pick_What_5th_Version.jsp
05/01/2021 12:44 PM
MDRIZWAN i confused to buy dpharma or pharmaniaga
05/01/2021 12:50 PM
MK76 tambah lagi 12.2 juta vaksin pfizer. Bila hang nak terbang dksh?
11/01/2021 3:42 PM
gloveharicut 2.19% over Total Capital

SUPERMAX & TOPGLOV is leading
FREIGHT & DKSH is the laggard

Stock Name Last Price Change Shares Market Value % Average Cost Per Share Unrealized Gain % Day Gain %
SUPERMX MYR 7.26 0.23 2,500 18,150.00 17.76% 15,060.54 6.024 3,089.46 20.51% 575 3.27%
TOPGLOV MYR 6.6 0.17 2,500 16,500.00 16.15% 15,335.89 6.134 1,164.11 7.59% 425 2.64%
HARTA MYR 12.52 0.3 1,200 15,024.00 14.70% 14,601.95 12.168 422.05 2.89% 360 2.45%
KGB MYR 1.64 0.02 5,900 9,676.00 9.47% 9,993.98 1.693 -317.98 -3.18% 118 1.23%
TASCO MYR 2.91 0.06 3,400 9,894.00 9.68% 10,258.32 3.017 -364.32 -3.55% 204 2.11%
KOSSAN MYR 4.39 0.04 3,300 14,487.00 14.18% 14,884.31 4.51 -397.31 -2.67% 132 0.92%
DKSH MYR 3.26 0 2,900 9,454.00 9.25% 9,853.79 3.397 -399.79 -4.06% 0 0.00%
FREIGHT MYR 0.825 0 10,900 8,992.50 8.80% 9,996.48 0.917 -1,003.98 -10.04% 0 0.00%

https://klse.i3investor.com/servlets/pfs/166413.jsp
12/01/2021 9:40 AM